Blockade of T-cell immunoglobulin mucin-3 (TIM-3), an alternative immune checkpoint which is upregulated in PD-1 blockaded tumors and also in tumor-infiltrating lymphocytes, has been shown to overcome resistance to PD-1 blockade [18]. Here, HAVCR2 is linked to neoplasm.